The Needleman Program for Innovation and Commercialization provides funding for researchers developing promising new therapeutics, helping them progress to early-stage clinical trials. A second call for proposals is now open.
The submission deadline is March 15. Learn more here (WUSTL Box login required).
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
